Pochert, Nicole
Schneider, Mariella
Köpke, Melitta B.
Wild, Mathis
Mattmer, Angelika
Sagasser, Jacqueline
Golas, Monika M.
Banys-Paluchowski, Maggie
Metz, Aline
Hinske, Christian
Reiger, Matthias
Jeschke, Udo http://orcid.org/0000-0003-2623-3235
Dannecker, Christian
Neumann, Avidan
Traidl-Hoffmann, Claudia
Untch, Michael
Kühn, Thorsten
Ditsch, Nina
Funding for this research was provided by:
Universität Augsburg
Article History
Received: 29 March 2023
Accepted: 4 May 2023
First Online: 27 May 2023
Declarations
:
: N.D. reports funding from MSD, Novartis, Pfizer, Roche, AstraZeneca, TEVA, Mentor, and MCI Healthcare. C.D. is funded by Roche, AstraZeneca, TEVA, Mentor, and MCI Healthcare. J.S. is funded by Novartis, Roche, Pfizer, BMS, and AstraZeneca. M.U. reports personal fees and non-financial support from Abbvie, personal fees and non-financial support from Amgen GmbH, personal fees and non-financial support from AstraZeneca, personal fees from BMS, personal fees and non-financial support from Celgene GmbH, personal fees and non-financial support from Daiji Sankyo, personal fees and non-financial support from Eisai GmbH, personal fees from Lilly Deutschland, personal fees and non-financial support from Lilly Int., personal fees and non-financial support from MSD Merck, personal fees and non-financial support from Mundipharma, personal fees and non-financial support from Myriad Genetics, personal fees and non-financial support from Odonate, personal fees and non-financial support from Pfizer GmbH, personal fees from PUMA Biotechnology, personal fees and non-financial support from Roche Pharma AG, personal fees and non-financial support from Sanofi Aventis Deutschland GmbH, personal fees and non-financial support from TEVA Pharmaceuticals Ind Ltd., personal fees and non-financial support from Novartis, personal fees from Pierre Fabre, personal fees and non-financial support from Clovis Oncology, and personal fees from Seattle Genetics, outside the submitted work. M.B.P. got funding from Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, Amgen, Samsung, Canon, MSD, GSK, Daiichi Sankyo, Gilead, Sirius Pintuition, Pierre Fabre, and ExactSciences. T.K. was funded by Endomag, Hologic, Mammotome, Merit Medical, Pfizer, Sirius Medical, Pfizer, Astra Zeneca, MSD, Gilead, Exact Sciences, and Daiichi-Sankyo. All other authors report no conflict of interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.